11th Edition of International Conference on
Neurology and Neurological Disorders
June 05-07, 2025 | Rome, Italy
Translational Neurology
The dynamic field of translational neurology focuses on converting scientific research into therapeutic strategies for complex neurological disorders. It explores the pathways of neurodegeneration, aiming to identify biomarkers and novel drug targets for early intervention. Through interdisciplinary collaboration, Translational Neurology leverages advancements in molecular biology, bioinformatics, and neuroengineering to design cutting-edge treatments. Techniques such as brain-machine interfaces and neurostimulation are emerging as transformative tools in restoring function for patients with neurological impairments. This approach emphasizes precision medicine, ensuring that therapies are tailored to the genetic and molecular profiles of individuals, ultimately driving progress in the treatment of challenging neurological conditions.
Ken Ware
NeuroPhysics Therapy Institute, Australia
Robert B Slocum
University of Kentucky HealthCare, United States
Luiz Moutinho
University of Suffolk, United Kingdom
David Lominadze
University of South Florida, United States
Dixie J Woolston
Mayo Clinic Arizona/Scottsdale, United States
David Sperbeck
Private Practice, United States
Sang Hie Lee
University of South Florida, United StatesSubmit your abstract Today
Title : Perception and individuality
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : ACE-dependent Alzheimer’s Disease (AD)
Sergei M Danilov, University of Illinois, United States
Title : Essential roles, mechanisms and consequences of vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Narrative medicine: A communication therapy for the communication disorder of Psychogenic Non-Epileptic Seizures (PNES) also known as Functional Seizures (FS)
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Who cares …… for the carers
Jaqueline Tuppen, COGS Club, United Kingdom
Title : Parkinson's disease, aging and mitochondria
Ming Guo, UCLA David Geffen School of Medicine, United States